Saturday 10 October 2026 Export all INNV data to Excel Powerpack

InnovAge Holding Corp.

InnovAge Holding Corp.’s revenue for fiscal 2026 (year ended June 2026) was $989.7 million, up 15.9% from fiscal 2025. In the quarter to June 2026, revenue grew 18.3%, EPS grew 700.0%, free cash flow grew 85.4% and total debt fell 16.3%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

9.10 0.01 −0.11%

Follow INNV

Alert me

Market cap: $1.2B
P/E: 0.0×
Fwd P/E: 17.2×
Dividend yield: —
F-score: 6/9
Altman Z: 4.58
Beneish M: −3.10
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 185.37

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	1	—	—	—	—	—	—	—	—	—	4	—

Insider Ownership 76.89%

Capital & Financial Ratios $m

Market Cap 1,240.00

Revenue 989.71

Net Income (0.68)

Free Cash Flow 54.12

Net Debt (85.03)

Current Ratio 1.05

Debt/Equity 0.24

P/E ratio 0.00

Fwd P/E 17.20

P/S ratio 1.25

P/B ratio 5.17

Past 5Y EPS Growth —

This Y EPS Growth 2,301.71%

Next Y EPS Growth 13.42%

Next Y revenue growth 8.52%

Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 65.84%

10-year low 10-year high

P/B against its own 10 years 86.39%

10-year low 10-year high

EV/Sales against its own 10 years 68.96%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	2026
Cash	173	103	106	141
Receivables	25	51	40	46
Inventory	—	—	—	—
Other	17	—	6	—
	215	173	176	214

	2023	2024	2025	2026
Payables	55	55	77	115
ST’ Debt	4	4	2	3
Other	52	71	76	75
	148	139	165	204

Compound Annual Growth %

	10y	5y	3y
Sales	—	9.19%	12.88%
Cash Flow	—	0.00%	47.33%
Earnings	—	0.00%	0.00%
Book Value	—	(6.88%)	(7.54%)

Revenue $m

	Sep	Dec	Mar	Jun	Year
’26	—	—	—	—	—
’26	236	240	252	262	990
’25	205	209	218	221	854
’24	182	189	193	199	764
’23	171	167	173	177	688
’22	173	175	177	173	699
’21	153	157	156	172	638

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Sep	Dec	Mar	Jun	Year
’26	—	—	—	—	—
’26	4	21	18	21	65
’25	(8)	7	25	9	33
’24	(33)	(9)	4	2	(37)
’23	13	(35)	29	13	20
’22	21	11	(8)	3	27
’21	(18)	17	(16)	9	(8)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Sep	Dec	Mar	Jun	Year
’26	—	—	—	—	—
’26	0	19	18	17	54
’25	(10)	5	22	9	27
’24	(36)	(11)	3	(1)	(45)
’23	5	(42)	24	9	(3)
’22	18	2	(17)	(15)	(11)
’21	(23)	8	(19)	6	(27)

Fiscal quarters ending in the months shown.

EPS $

	Sep	Dec	Mar	Jun	Year
’26	—	—	—	—	—
’26	0.06	0.08	(0.22)	0.06	(0.02)
’25	(0.04)	(0.10)	(0.08)	(0.01)	(0.22)
’24	(0.08)	(0.03)	(0.04)	(0.01)	(0.16)
’23	(0.10)	(0.07)	(0.05)	(0.09)	(0.30)
’22	0.06	0.01	(0.02)	(0.09)	(0.05)
’21	(0.41)	0.08	(0.09)	0.05	(0.36)

Fiscal quarters ending in the months shown.

Group	Line	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026	2027e
Price, $
Price, $	Low	—	—	—	—	3.46	3.39	5.04	3.52	2.60	5.16	Analyst estimates 2027–2029 Powerpack
	High	—	—	—	—	27.18	7.85	8.15	6.69	6.26	12.64
People
People	Employees	—	—	—	1,910	1,800	2,000	2,100	2,350	2,440	2,500
	Revenue/emp, $m	—	—	0.00	0.30	0.35	0.35	0.33	0.33	0.35	0.40
Income, $m
Income, $m	Revenue	—	—	466	567	638	699	688	764	854	990
	Gross margin, %	—	—	23.76	24.91	27.29	19.38	14.72	17.29	18.00	23.01
	EBT	—	—	25	36	(35)	(7)	(51)	(22)	(34)	0
	EBT margin, %	—	—	5.45	6.28	(5.48)	(1.04)	(7.38)	(2.86)	(3.99)	0.03
	Net income	0	—	19	26	(45)	(8)	(44)	(23)	(35)	(1)
	Depreciation	—	—	10	12	13	14	16	19	20	22
Per share, $
Per share, $	Revenue	—	—	3.52	4.28	5.16	5.16	5.07	5.62	6.31	7.29
	Earnings	—	—	0.14	0.19	(0.36)	(0.05)	(0.30)	(0.16)	(0.22)	(0.02)
	Cash flow	—	—	0.20	0.33	(0.06)	0.20	0.15	(0.27)	0.24	0.48
	Capex	—	—	(0.11)	(0.09)	(0.16)	(0.28)	(0.17)	(0.06)	(0.05)	(0.08)
	Free cash flow	—	—	0.09	0.24	(0.22)	(0.08)	(0.02)	(0.33)	0.20	0.40
	Book value	—	—	0.62	0.81	2.76	2.50	2.23	2.04	1.76	1.76
	Shares, m	—	—	132	133	124	136	136	136	135	136
Valuation, ×
Valuation, ×	P/E	—	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	P/S	—	—	4.64	4.64	4.13	0.85	1.48	0.90	0.59	1.62
	P/B	—	—	0.00	0.00	7.73	1.75	3.37	2.47	2.10	6.73
	EV/Sales	—	—	5.01	5.01	3.94	0.70	1.34	0.86	0.54	1.54
	EV/FCF	—	—	152.51	152.51	(100.09)	(34.13)	(141.15)	(13.68)	19.90	30.05
Cash, $m
Cash, $m	Operating cash flow	—	—	26	44	(8)	27	20	(37)	33	65
	Capex	—	—	(14)	(12)	(20)	(38)	(23)	(8)	(6)	(11)
	Free cash flow	—	—	11	32	(27)	(11)	(3)	(45)	27	54
Balance, $m
Balance, $m	Working capital	—	—	36	90	172	136	67	35	11	10
	Total debt	—	—	193	216	81	81	82	78	67	56
	Net debt	—	—	132	102	(123)	(103)	(92)	(25)	(39)	(85)
	Shareholders’ equity	—	—	81	108	341	338	302	278	238	239
Returns, %
Returns, %	ROA	—	—	10.78	6.80	(9.34)	(1.20)	(7.24)	(3.83)	(5.64)	(0.47)
	ROIC	—	—	11.62	15.18	(3.54)	(1.17)	(14.68)	(5.73)	(9.34)	1.06
	ROE	—	—	22.35	27.78	(19.60)	(1.92)	(12.70)	(7.36)	(11.76)	(1.06)

Negative figures in brackets.

All 10 years →

Fiscal years to Jun 2026 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
CMPS COMPASS Pathways PLC Sponsored ADR	$1.6B	— (loss-making)	—	—	n/m	−4.18% (below 0%: shrinking)	—	0.00%	Compare
ARDT Ardent Health, Inc.	$1.6B	20.5×	7.7×	−1.40% (below 0%: shrinking)	−76.92% (below 0%: shrinking)	+121.70% (above 0%: growing)	100.00%	3.44%	Compare
AGL Agilon Health, Inc.	$1.4B	— (loss-making)	— (loss-making)	+7.15% (above 0%: growing)	n/m	−50.19% (below 0%: shrinking)	7.17%	0.79%	Compare
HCSG Healthcare Services Group, Inc.	$1.4B	11.9×	19.2×	+2.69% (above 0%: growing)	n/m	−26.02% (below 0%: shrinking)	15.89%	4.72%	Compare
PNTG The Pennant Group, Inc.	$1.4B	42.3×	26.9×	+35.76% (above 0%: growing)	+23.81% (above 0%: growing)	−50.94% (below 0%: shrinking)	14.07%	5.77%	Compare
NUTX Nutex Health Inc.	$1.4B	7.9×	6.3×	−13.62% (below 0%: shrinking)	n/m	+19.44% (above 0%: growing)	67.04%	57.75%	Compare
AMN AMN Healthcare Services Inc	$1.4B	13.5×	31.2×	+2.29% (above 0%: growing)	n/m	−389.43% (below 0%: shrinking)	30.58%	4.00%	Compare
USPH U.S. Physical Therapy, Inc.	$1.3B	498×	27.7×	+8.47% (above 0%: growing)	−56.90% (below 0%: shrinking)	−8.24% (below 0%: shrinking)	19.59%	10.25%	Compare
INNV InnovAge Holding Corp.	$1.2B	— (loss-making)	17.2×	+18.31% (above 0%: growing)	n/m	+85.44% (above 0%: growing)	23.88%	3.87%
Median of peers	$1.4B	17.0×	23.0×	+2.69%	−56.90%	−17.13%	19.59%	4.36%

All 55 Medical Care Facilities stocks →

InnovAge Holding Corp. (INNV) key facts

Concern: InnovAge Holding Corp. reported a net loss of $683,000.00, or a loss of $0.02 per share, for fiscal 2026.
Strength: InnovAge Holding Corp.’s revenue for fiscal 2026 (year ended June 2026) was $989.7 million, up 15.9% from fiscal 2025.
InnovAge Holding Corp. (INNV) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
As of October 9, 2026, INNV traded at $9.10, a market capitalization of $1.2 billion.
Trailing earnings are negative, so a P/E ratio is not meaningful; the stock trades at 1.2× sales.
Return on equity was −1.06% and debt-to-equity 0.24.
Its Piotroski F-score is 6 out of 9 and its Altman Z-score is 4.58 (safe zone) for fiscal 2026.